Your browser doesn't support javascript.
loading
Human equilibrative nucleoside transporter 1 and human concentrative nucleoside transporter 3 predict survival after adjuvant gemcitabine therapy in resected pancreatic adenocarcinoma.
Maréchal, Raphaël; Mackey, John R; Lai, Raymond; Demetter, Pieter; Peeters, Marc; Polus, Marc; Cass, Carol E; Young, James; Salmon, Isabelle; Devière, Jacques; Van Laethem, Jean-Luc.
Affiliation
  • Maréchal R; Department of Gastroenterology and Hepato-Pancreatology, Gastrointestinal Cancer Unit, and Department of Pathology, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium. rmarecha@ulb.ac.be
Clin Cancer Res ; 15(8): 2913-9, 2009 Apr 15.
Article in En | MEDLINE | ID: mdl-19318496
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Membrane Transport Proteins / Adenocarcinoma / Equilibrative Nucleoside Transporter 1 / Deoxycytidine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: Belgium Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Membrane Transport Proteins / Adenocarcinoma / Equilibrative Nucleoside Transporter 1 / Deoxycytidine Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2009 Document type: Article Affiliation country: Belgium Country of publication: United States